Testing Gene PilotLX With Latinx Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

December 31, 2027

Conditions
Cancer
Interventions
OTHER

Gene PilotLX

eHealth decision making tool regarding tumor genomic profiling

Trial Locations (4)

10032

NOT_YET_RECRUITING

Herbert Irving Comprehensive Cancer Center, New York

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

19122

RECRUITING

Temple University Hospital, Philadelphia

08103

NOT_YET_RECRUITING

MD Anderson Cancer Center at Cooper, Camden

All Listed Sponsors
collaborator

Temple University

OTHER

collaborator

MD Anderson Cancer Center at Cooper

OTHER

collaborator

Herbert Irving Comprehensive Cancer Center

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT06476938 - Testing Gene PilotLX With Latinx Cancer Patients | Biotech Hunter | Biotech Hunter